Skip to Main Content

Paper Details

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.
Br J Cancer
19
2022
CCA, Cholangiocarcinoma, FGFR2, FGFR2 fusion, FGFR2 fusions, FGFR2 gene fusions, Pemigatinib, cholangiocarcinoma, iCCA, intrahepatic CCA, primary malignancy of the biliary tract, tumours
Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cholangiocarcinoma, Genomics, Humans, Molecular Diagnostic Techniques, Receptor, Fibroblast Growth Factor, Type 2
Author NameAffiliation
Olaf NeumannInstitute of Pathology, University Hospital Heidelberg
Olaf NeumannCenter for Personalized Medicine Heidelberg (ZPM)
Olaf Neumann
Timothy C BurnFormerly employed by Incyte Research Institute
Timothy C Burn
Michael Allg??uerInstitute of Pathology, University Hospital Heidelberg
Markus BallInstitute of Pathology, University Hospital Heidelberg
Markus BallTranslational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL)
Martina KirchnerInstitute of Pathology, University Hospital Heidelberg
Thomas AlbrechtInstitute of Pathology, University Hospital Heidelberg
Anna-Lena VolckmarInstitute of Pathology, University Hospital Heidelberg
Susanne BeckInstitute of Pathology, University Hospital Heidelberg
Volker EndrisInstitute of Pathology, University Hospital Heidelberg
Hannah GoldschmidInstitute of Pathology, University Hospital Heidelberg
Ulrich LehmannInstitute of Pathology, Hannover Medical School
Huriye Seker-CinInstitute of Pathology, University Hospital Heidelberg
Sebastian UhrigNational Center for Tumor Diseases (NCT) Heidelberg
Sebastian UhrigGerman Cancer Research Center (DKFZ)
Stephanie RoesslerInstitute of Pathology, University Hospital Heidelberg
Jan BudcziesInstitute of Pathology, University Hospital Heidelberg
Jan BudcziesCenter for Personalized Medicine Heidelberg (ZPM)
Stefan Fr??hlingCenter for Personalized Medicine Heidelberg (ZPM)
Stefan Fr??hling
Stefan Fr??hlingGerman Cancer Research Center (DKFZ)
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg
Thomas LongerichInstitute of Pathology, University Hospital Heidelberg
Thomas LongerichLiver Cancer Center Heidelberg
Alex H WagnerThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital
Alex H WagnerThe Ohio State University College of Medicine
Arndt VogelHannover Medical School
Peter SchirmacherInstitute of Pathology, University Hospital Heidelberg
Peter SchirmacherCenter for Personalized Medicine Heidelberg (ZPM)
Peter Schirmacher
Peter SchirmacherLiver Cancer Center Heidelberg
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Albrecht StenzingerCenter for Personalized Medicine Heidelberg (ZPM)
Albrecht Stenzinger
Albrecht StenzingerTranslational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL)
Daniel KazdalInstitute of Pathology, University Hospital Heidelberg
Daniel KazdalCenter for Personalized Medicine Heidelberg (ZPM)
Daniel Kazdal
Daniel KazdalTranslational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL)
  • 1 - 42

Datasets